{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:19:14Z","timestamp":1792135154486,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.kint.2026.03.019","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:32:29Z","timestamp":1777332749000},"page":"413-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy"],"prefix":"10.1016","volume":"110","author":[{"given":"Dominik","family":"Kentrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane Joy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Courbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Hunt-Tobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo J.","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Semanchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9527-2364","authenticated-orcid":false,"given":"Valentin","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-9294","authenticated-orcid":false,"given":"Aline","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.03.019_bib1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1681\/ASN.2016050562","article-title":"Global cardiovascular and renal outcomes of reduced GFR","volume":"28","author":"Thomas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.019_bib2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2026.03.019_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2026.03.019_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41581-023-00784-z","article-title":"Differences in the epidemiology, management and outcomes of kidney disease in men and women","volume":"20","author":"Chesnaye","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.03.019_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneph.2017.181","article-title":"Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease","volume":"14","author":"Carrero","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.03.019_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254554","article-title":"Relationship between sex and cardiovascular mortality in chronic kidney disease: a systematic review and meta-analysis","volume":"16","author":"Shajahan","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2026.03.019_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f324","article-title":"Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis","volume":"346","author":"Nitsch","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2026.03.019_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ajkd.2020.11.026","article-title":"CKD progression and mortality among men and women: a nationwide study in Sweden","volume":"78","author":"Swartling","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.03.019_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.kint.2026.03.019_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00021.2015","article-title":"Mechanistic pathways of sex differences in cardiovascular disease","volume":"97","author":"Regitz-Zagrosek","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.kint.2026.03.019_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2017.12","article-title":"The effects of oestrogens and their receptors on cardiometabolic health","volume":"13","author":"Morselli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.kint.2026.03.019_bib12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","article-title":"Molecular and cellular basis of cardiovascular gender differences","volume":"308","author":"Mendelsohn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.kint.2026.03.019_bib13","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2026.03.019_bib14","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0002-9149(99)00029-6","article-title":"Effect of hormone replacement therapy on left ventricular hypertrophy","volume":"83","author":"Lim","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.kint.2026.03.019_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJM199304153281501","article-title":"Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: the Atherosclerosis Risk in Communities Study Investigators","volume":"328","author":"Nabulsi","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.03.019_bib16","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.04013","article-title":"Estrogen signaling in the cardiovascular system","volume":"4","author":"Kim","year":"2006","journal-title":"Nuclear Receptor Signaling"},{"key":"10.1016\/j.kint.2026.03.019_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/HYPERTENSIONAHA.110.166157","article-title":"Estrogen receptor-beta signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetate-salt mice","volume":"57","author":"Gurgen","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2026.03.019_bib18","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/en.2008-0133","article-title":"Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin","volume":"149","author":"Pedram","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2026.03.019_bib19","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1007\/s00018-008-8273-1","article-title":"Repression of NFAT3 transcriptional activity by estrogen receptors","volume":"65","author":"Qin","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.kint.2026.03.019_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.lfs.2005.04.077","article-title":"17beta-Estradiol reduces cardiac hypertrophy mediated through the up-regulation of PI3K\/Akt and the suppression of calcineurin\/NF-AT3 signaling pathways in rats","volume":"78","author":"Wu","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.kint.2026.03.019_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCRESAHA.108.190397","article-title":"Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation","volume":"104","author":"Donaldson","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2026.03.019_bib22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2017.12.019","article-title":"Menopause in CKD","volume":"71","author":"Vellanki","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.03.019_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41581-023-00717-w","article-title":"Menopause and chronic kidney disease","volume":"20","author":"Dines","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.03.019_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.03.019_bib25","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2026.03.019_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.019_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","article-title":"Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease","volume":"91","author":"Munoz Mendoza","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.019_bib28","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.019_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.019_bib30","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2026.03.019_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2215\/CJN.02110217","article-title":"FGF23 and left ventricular hypertrophy in children with CKD","volume":"13","author":"Mitsnefes","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.019_bib32","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2026.03.019_bib33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2026.03.019_bib34","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ndt\/gfx332","article-title":"Genetic background influences cardiac phenotype in murine chronic kidney disease","volume":"33","author":"Neuburg","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.03.019_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41413-021-00154-0","article-title":"Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease","volume":"9","author":"Courbon","year":"2021","journal-title":"Bone Res"},{"key":"10.1016\/j.kint.2026.03.019_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.019_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41413-019-0051-1","article-title":"DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease","volume":"7","author":"Dussold","year":"2019","journal-title":"Bone Res"},{"key":"10.1016\/j.kint.2026.03.019_bib38","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.kint.2019.07.026","article-title":"Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease","volume":"96","author":"Francis","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.03.019_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/laban0109-35","article-title":"A method for gender determination in newborn dark pigmented mice","volume":"38","author":"Wolterink-Donselaar","year":"2009","journal-title":"Lab Anim (NY)"},{"key":"10.1016\/j.kint.2026.03.019_bib40","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","article-title":"Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome","volume":"10","author":"Cosgrove","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.kint.2026.03.019_bib41","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1681\/ASN.2006020165","article-title":"Loss of alpha3\/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-\/- Alport mice","volume":"17","author":"Kang","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.019_bib42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"Stubbs","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.kint.2026.03.019_bib43","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/hmg\/3.8.1269","article-title":"Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome","volume":"3","author":"Lemmink","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.kint.2026.03.019_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.ackd.2013.06.007","article-title":"Women and CKD-mineral and bone disorder","volume":"20","author":"Ho","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2026.03.019_bib45","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","article-title":"Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease","volume":"26","author":"O'Seaghdha","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.03.019_bib46","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2026.03.019_bib47","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2011.06.011","article-title":"Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study","volume":"58","author":"Ix","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.03.019_bib48","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/ndt\/gfq191","article-title":"Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?","volume":"25","author":"Olauson","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.03.019_bib49","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2026.03.019_bib50","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1681\/ASN.2008121258","article-title":"Indirect regulation of PTH by estrogens may require FGF23","volume":"20","author":"Carrillo-Lopez","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.03.019_bib51","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1210\/en.2013-1627","article-title":"Calcium regulates FGF-23 expression in bone","volume":"154","author":"David","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2026.03.019_bib52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11357-021-00331-3","article-title":"Alterations in the estrogen receptor profile of cardiovascular tissues during aging","volume":"43","author":"Gurrala","year":"2021","journal-title":"Geroscience"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826003091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826003091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:58:28Z","timestamp":1784541508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826003091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0085253826003091"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.03.019","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}